AI assistant
Smith & Nephew PLC — Director's Dealing 2019
May 3, 2019
4588_dirs_2019-05-03_3241970e-a506-4cff-a12b-012e90c2d609.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 0347Y
Smith & Nephew Plc
03 May 2019
SMITH & NEPHEW PLC
3 May 2019
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Roland Diggelmann
2
Reason for the notification
a)
Position/status
Non-Executive Director
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Smith & Nephew plc
b)
LEI
213800ZTMDN8S67S1H61
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Smith & Nephew plc ordinary shares of USD 0.20 each
ISIN: GB0009223206
b)
Nature of the transaction
Purchase of ordinary shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £15.3211202 | 1,540 |
d)
Aggregated information
- Aggregated volume
- Price
Single Transaction
N/A
N/A
e)
Date of the transaction
2019 - 05 - 03
f)
Place of the transaction
XLON
Susan Swabey
Company Secretary
Smith & Nephew plc
Tel: 01923 477216
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHLIFIAETIVIIA